11月17日，通化金马盘中上涨2.23%，截至11:05，报29.39元/股，成交3.93亿元，换手率1.41%，总市值 284.05亿元。 资金流向方面，主力资金净流出1759.63万元，特大单买入2862.41万元，占比7.28%，卖出4253.98万 元，占比10.82%；大单买入1.15亿元，占比29.36%，卖出1.19亿元，占比30.29%。 通化金马所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：民营医院、工业大麻、 东北振兴、肝炎治疗、中药等。 截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 ...

Core Viewpoint - The stock of Shouxiangu has shown a slight increase in recent trading sessions, with a notable rise in trading volume and a positive net inflow of funds, indicating investor interest despite a decline in revenue and profit year-on-year [1][2]. Company Overview - Shouxiangu Pharmaceutical Co., Ltd. is located in Wuyi County, Zhejiang Province, and was established on March 3, 1997. It was listed on May 10, 2017. The company specializes in the breeding, cultivation, processing, and sales of valuable traditional Chinese medicinal materials such as Ganoderma and Dendrobium [2]. - The main business revenue composition includes: Ganoderma spore powder products (71.92%), Dendrobium products (15.57%), other products (10.88%), and supplementary products (1.63%) [2]. Stock Performance - As of November 14, the stock price of Shouxiangu increased by 2.16%, reaching 21.30 CNY per share, with a trading volume of 33.55 million CNY and a turnover rate of 0.80%. The total market capitalization is 4.22 billion CNY [1]. - Year-to-date, the stock price has risen by 1.72%, with a 3.60% increase over the last five trading days, a 3.40% increase over the last 20 days, and a 3.75% decrease over the last 60 days [2]. Financial Performance - For the period from January to September 2025, Shouxiangu reported a revenue of 430 million CNY, a year-on-year decrease of 8.88%. The net profit attributable to the parent company was 76.34 million CNY, down 35.67% year-on-year [2]. - Since its A-share listing, Shouxiangu has distributed a total of 436 million CNY in dividends, with 218 million CNY distributed in the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Shouxiangu was 22,700, a decrease of 4.31% from the previous period. The average circulating shares per person increased by 4.51% to 8,727 shares [2]. - Among the top ten circulating shareholders, the Rongtong Health Industry Flexible Allocation Mixed A/B fund holds 1.2823 million shares, an increase of 82,300 shares compared to the previous period [3].

Core Viewpoint - Jifeng Technology's stock price has seen a significant increase of 65.55% year-to-date, despite a recent decline of 2.09% in intraday trading on November 14, 2023, indicating volatility in the market [1]. Group 1: Stock Performance - As of November 14, 2023, Jifeng Technology's stock price is reported at 8.89 CNY per share, with a market capitalization of 4.394 billion CNY [1]. - The stock has experienced a trading volume of 40.47 million CNY, with a turnover rate of 0.91% [1]. - Year-to-date, the stock has increased by 65.55%, with a 3.37% rise over the last five trading days, 1.48% over the last 20 days, and 3.86% over the last 60 days [1]. Group 2: Financial Performance - For the period from January to September 2025, Jifeng Technology reported a revenue of 2.224 billion CNY, reflecting a year-on-year growth of 3.47% [2]. - The company recorded a net profit attributable to shareholders of -7.315 million CNY, which represents a year-on-year increase of 69.62% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Jifeng Technology has increased to 21,300, marking a rise of 9.68% from the previous period [2]. - The average number of circulating shares per shareholder is 23,206, which has decreased by 8.83% compared to the previous period [2]. - Since its A-share listing, Jifeng Technology has distributed a total of 53.61 million CNY in dividends, with no dividends paid in the last three years [3]. Group 4: Company Overview - Jifeng Technology, established on December 8, 1994, and listed on October 30, 2009, is based in Chengdu, Sichuan Province, and specializes in the sales and services of modern agricultural equipment, including agricultural machinery, cargo vehicles, and engineering machinery [1]. - The company's revenue composition indicates that 90.33% comes from the agricultural machinery distribution segment, while 9.67% is from the agricultural machinery manufacturing segment [1]. - Jifeng Technology is categorized under the Shenyin Wanguo industry classification of retail trade - professional chain II - professional chain III, and is associated with concepts such as rural revitalization, ecological agriculture, rural e-commerce, industrial hemp, and supply cooperative concepts [1].

Group 1 - The core viewpoint of the news is that Sanlisi's stock has shown positive performance with a year-to-date increase of 10.49% and a recent uptick of 4.41% over the last five trading days [1] - As of November 13, Sanlisi's stock price reached 4.74 yuan per share, with a total market capitalization of 4.276 billion yuan [1] - The company has seen a net inflow of main funds amounting to 8.2264 million yuan, indicating strong investor interest [1] Group 2 - For the period from January to September 2025, Sanlisi achieved an operating income of 714 million yuan, reflecting a year-on-year growth of 21.75% [2] - However, the net profit attributable to shareholders decreased by 45.76% to 27.6511 million yuan during the same period [2] - The number of shareholders increased slightly to 51,200, while the average circulating shares per person decreased by 0.02% to 15,742 shares [2] Group 3 - Since its A-share listing, Sanlisi has distributed a total of 463 million yuan in dividends, with 89.7271 million yuan distributed over the past three years [3]

Company Overview - Qizhou Dongfeng New Materials Group Co., Ltd. is located in Shantou, Guangdong Province, and was established on December 30, 1983. The company was listed on February 16, 2012. Its main business involves the design, production, and sales of cigarette labels and related packaging materials [1][2]. Financial Performance - For the period from January to September 2025, Qizhou Dongfeng achieved operating revenue of 916 million yuan, a year-on-year decrease of 12.54%. The net profit attributable to the parent company was -95.4971 million yuan, representing a year-on-year increase of 49.83% [2]. - The company has cumulatively distributed 4.134 billion yuan in dividends since its A-share listing, with a total of 46.0741 million yuan distributed over the past three years [3]. Stock Performance - As of November 13, Qizhou Dongfeng's stock price increased by 2.05%, reaching 4.97 yuan per share, with a total market capitalization of 9.262 billion yuan. The stock has risen by 24.87% year-to-date, with a recent decline of 0.40% over the last five trading days [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on January 24 [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Qizhou Dongfeng was 31,500, a decrease of 11.45% from the previous period. The average circulating shares per person increased by 12.28% to 59,077 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 11.9868 million shares, a decrease of 932,700 shares compared to the previous period [3]. Industry Classification - Qizhou Dongfeng is classified under the light industry manufacturing sector, specifically in packaging and printing, with a focus on paper packaging. The company is associated with concepts such as low price, state-owned enterprise reform, small-cap stocks, industrial hemp, and margin financing [2].

Core Viewpoint - Yunnan Chengtou's stock price has shown a slight increase this year, but recent trading data indicates a net outflow of funds, suggesting potential investor concerns about the company's performance and market position [1][2]. Financial Performance - For the period from January to September 2025, Yunnan Chengtou reported operating revenue of 1.336 billion yuan, a year-on-year decrease of 2.97% [2]. - The company recorded a net profit attributable to shareholders of -35.22 million yuan, representing a significant year-on-year decline of 296.01% [2]. Stock Market Activity - As of November 12, Yunnan Chengtou's stock price was 2.72 yuan per share, with a market capitalization of 4.367 billion yuan [1]. - The stock has increased by 1.87% year-to-date, with a 0.74% rise over the last five trading days, a 5.02% increase over the last 20 days, and a 9.68% increase over the last 60 days [1]. Shareholder Information - As of October 31, the number of shareholders for Yunnan Chengtou was 54,200, an increase of 3.25% from the previous period [2]. - The average number of circulating shares per shareholder was 29,629, a decrease of 3.15% from the previous period [2]. Dividend History - Since its A-share listing, Yunnan Chengtou has distributed a total of 707 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder was the Southern CSI Real Estate ETF, holding 12.1863 million shares, which is a decrease of 82,200 shares from the previous period [3].

Core Points - The stock price of Shunhao Co., Ltd. decreased by 2.18% on November 12, trading at 7.17 yuan per share with a market capitalization of 7.6 billion yuan [1] - The company has seen a year-to-date stock price increase of 138.92%, but has experienced a decline of 5.03% over the last five trading days [1] - Shunhao Co. reported a revenue of 899 million yuan for the first nine months of 2025, a year-on-year decrease of 20.57%, while net profit attributable to shareholders increased by 20.29% to 67.32 million yuan [2] Company Overview - Shunhao Co. was established on December 21, 2004, and went public on March 18, 2011. The company is located in Putuo District, Shanghai [1] - The main business activities include the research, production, processing, and sales of vacuum aluminum-coated paper, composite film paper, white cardboard, printed products, and tobacco polypropylene fiber bundles [1] - The revenue composition of the company includes printed products (48.07%), aluminum-coated paper (30.03%), and other categories [1] Shareholder Information - As of September 30, the number of shareholders for Shunhao Co. was 43,900, a decrease of 4.61% from the previous period [2] - The average number of circulating shares per shareholder increased by 4.83% to 24,123 shares [2] Dividend Information - Since its A-share listing, Shunhao Co. has distributed a total of 427 million yuan in dividends, with 68.81 million yuan distributed over the past three years [3]

Core Viewpoint - Tonghua Jinma's stock price has shown significant growth this year, with a year-to-date increase of 76.75%, despite a slight decline in the last five trading days [1][2]. Financial Performance - For the period from January to September 2025, Tonghua Jinma reported operating revenue of 892 million yuan, a year-on-year decrease of 7.88%, while the net profit attributable to shareholders increased by 4.35% to 24.96 million yuan [2]. - The company has cumulatively distributed 210 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of November 11, 2023, Tonghua Jinma's stock was trading at 27.75 yuan per share, with a market capitalization of 26.82 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" twice this year, with the most recent net purchase of 142 million yuan on September 11 [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders was 38,200, a decrease of 3.20% from the previous period, with an average of 25,266 circulating shares per shareholder, an increase of 3.31% [2][3]. - Notable shareholders include Innovation Drug and Southern CSI 1000 ETF, with changes in their holdings compared to the previous period [3].

Core Viewpoint - Dezheng Health's stock price has experienced fluctuations, with a year-to-date increase of 39.30%, but a recent decline in trading performance [1][2]. Group 1: Stock Performance - On November 11, Dezheng Health's stock fell by 2.02%, trading at 4.36 CNY per share, with a total market capitalization of 9.143 billion CNY [1]. - The stock has seen a net outflow of 21.3992 million CNY in principal funds, with significant selling pressure observed [1]. - Year-to-date, the stock has risen by 39.30%, but has seen a slight decline of 1.13% over the last five trading days [1]. Group 2: Financial Performance - For the period from January to September 2025, Dezheng Health reported a revenue of 278 million CNY, a year-on-year decrease of 21.71%, and a net profit attributable to shareholders of -61.0254 million CNY, a significant decline of 854.37% [2]. - The company has not distributed any dividends in the last three years, with a total payout of 470 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 57,600, with an average of 36,404 circulating shares per person, reflecting a slight decline [2]. - The Hong Kong Central Clearing Limited has exited the list of the top ten circulating shareholders [3].

Core Viewpoint - Yunnan Chengtou's stock price has shown a positive trend with a year-to-date increase of 4.87%, reflecting a growing interest in the company's performance despite recent financial challenges [1][2]. Financial Performance - For the period from January to September 2025, Yunnan Chengtou reported operating revenue of 1.336 billion yuan, a year-on-year decrease of 2.97% [2]. - The company recorded a net profit attributable to shareholders of -35.22 million yuan, representing a significant year-on-year decline of 296.01% [2]. Stock Market Activity - On November 11, Yunnan Chengtou's stock rose by 2.19%, reaching 2.80 yuan per share, with a trading volume of 107 million yuan and a turnover rate of 2.41% [1]. - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent instance on September 24, where it saw a net purchase of 2.35 million yuan [1]. Shareholder Information - As of October 31, 2025, Yunnan Chengtou had 54,200 shareholders, an increase of 3.25% from the previous period [2]. - The average circulating shares per person decreased by 3.15% to 29,629 shares [2]. Dividend History - Since its A-share listing, Yunnan Chengtou has distributed a total of 707 million yuan in dividends, with no dividends paid in the last three years [3]. Institutional Holdings - As of September 30, 2025, the sixth largest circulating shareholder is the Southern CSI Real Estate ETF, holding 12.1863 million shares, a decrease of 82,200 shares from the previous period [3].